Antiretroviral therapy coverage in Nepal
Nepal: Antiretroviral therapy coverage was 77.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Nepal, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Nepal is 77.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 6.9% on the previous year and up 196.2% over ten years.
Over the whole period, antiretroviral therapy coverage in Nepal peaked at 77.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Nepal 59th out of 143 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Nepal, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 3.0% | +200.0% |
| 2008 | 6.0% | +100.0% |
| 2009 | 9.0% | +50.0% |
| 2010 | 12.0% | +33.3% |
| 2011 | 16.0% | +33.3% |
| 2012 | 19.0% | +18.8% |
| 2013 | 22.0% | +15.8% |
| 2014 | 26.0% | +18.2% |
| 2015 | 31.0% | +19.2% |
| 2016 | 34.0% | +9.7% |
| 2017 | 41.0% | +20.6% |
| 2018 | 46.0% | +12.2% |
| 2019 | 51.0% | +10.9% |
| 2020 | 56.0% | +9.8% |
| 2021 | 62.0% | +10.7% |
| 2022 | 67.0% | +8.1% |
| 2023 | 72.0% | +7.5% |
| 2024 | 77.0% | +6.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.9% | 0.0% | 9.0% | 10 |
| 2010s | 29.8% | 12.0% | 51.0% | 10 |
| 2020s | 66.8% | 56.0% | 77.0% | 5 |
Countries ranked near Nepal
- 57 Côte d'Ivoire 78.0% compare
- 57 Guatemala 78.0% compare
- 59 United Arab Emirates 77.0% compare
- 61 Canada 76.0% compare
- 61 El Salvador 76.0% compare
- 61 Mauritania 76.0% compare
- 61 Morocco 76.0% compare
More health data for Nepal
- Un projection of annual infant deaths, annual growth rate -1.95 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8518 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,326 deaths per 1,000 people (2090)
- Number of infants who die before age 1 955 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate -1.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0451 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Nepal?
- Antiretroviral therapy coverage in Nepal was 77.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Nepal?
- The highest recorded value was 77.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Nepal?
- The lowest recorded value was 0.0% in 2000.
- How does Nepal rank for antiretroviral therapy coverage?
- Nepal ranks 59th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Nepal?
- Over the last ten years it is up 196.2%. The long-run trend across the full record is volatile.
- Where does this Nepal data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.